What is the main business of Neomed Polska?

The main business activity of Neomed Polska focuses on wholesale of pharmaceutical goods.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on March 4, 2014.

Where is the headquarters located?

The headquarters is located at: Orężna 6 A, 05-501 Piaseczno.

Who is on the management board?

The management board includes Maciej Wrona (President of the Management Board).

What is the share capital?

The share capital of the company is PLN 50,000 (approx. $13,506).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.

What was the revenue?

In 2024, the company generated total revenue of $10,087,561, representing a decrease of 1.6% compared to 2023.

Is the company profitable?

Yes, the company recorded a net profit of $514,222 in 2024, meaning the company increased its profit by 8.3%.

What is the main operating cost?

The largest operating cost category falls under cost of goods and materials sold. This category amounted to $8,588,270 in 2024, representing 92% of all operating expenses.

Neomed Polskasp. z o.o.

Wholesale of pharmaceutical goods

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2014-03-04

Share capital

50 000,00 PLN

Registered address

Orężna 6 A, 05-501 Piaseczno, Poland

Website

neomedpolska.pl

Phone

Electronic delivery address

AE:PL-20128-25777-HJVWT-16

Financials

Revenue history (in m)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue

This companyUSD 8.87mMedianUSD 874.80kAverageUSD 20.28m

Net profit

This companyUSD 182.99kMedianUSD 28.35kAverageUSD 814.56k

Operating costs

This companyUSD 8.31mMedianUSD 805.63kAverageUSD 19.07m

Assets

This companyUSD 2.55mMedianUSD 541.39kAverageUSD 10.93m

News

2018-09-10

Neomed Polska became the exclusive distributor of the PrionTex brand

2018-06-01

Neomed Polska is the exclusive distributor of Bismed company

2018-06-01

Neomed Polska expands its offer with specialized medical products for the military

2018-06-01

Neomed expands its fleet of new vehicles

Industry

Bank accounts

Registered as a VAT taxpayer on 2014-04-01. Active

PKO Bank Polski
08 1020 1169 0000 8802 0208 7179

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Public aid

Grant date	Purpose	Gross amount	Granting body
Jan 8, 2026	De minimis aid (in accordance with Commission Regulation 2023/2831)	$21$21	Tauron Sprzedaż Gze sp. z o.o.

Tenders

728 tenders recorded as contractor: 296 national ($5,203,313) and 432 EU ($394,002,062).

Publication date	Subject	Amount	Contracting authority
Oct 9, 2026	Zakup produktów leczniczych, materiałów opatrunkowych, rękawic, wyrobów medycznych, mleka i innych według załączonych 180 pakietów na okres 24 miesięcy	––	Specjalistyczny Szpital Im. Dra Alfreda Sokołowskiego
Oct 9, 2026	Zakup produktów leczniczych, materiałów opatrunkowych, rękawic, wyrobów medycznych, mleka i innych według załączonych 180 pakietów na okres 24 miesięcy	––	Specjalistyczny Szpital Im. Dra Alfreda Sokołowskiego
Oct 8, 2026	Sukcesywna dostawa materiałów medycznych jednorazowego i wielorazowego użytku do apteki szpitalnej.	––	Szpital w Ostródzie S.A.

Public sector contracts

Contracts in the Central Register of Contracts: 109 · total value PLN 4,912,218 · public buyers: 56 · latest signed Oct 8, 2026

WOJEWÓDZKI SZPITAL ZESPOLONY W ELBLĄGUcontracts: 3 · PLN 1,741,680SAMODZIELNY PUBLICZNY WOJEWÓDZKI SZPITAL CHIRURGII URAZOWEJ IM.DR.JANUSZA DAABA W PIEKARACH ŚLĄSKICHcontracts: 2 · PLN 586,540SPECJALISTYCZNY SZPITAL IM. DRA ALFREDA SOKOŁOWSKIEGOcontracts: 1 · PLN 492,570

Signed	Subject	Public buyer	Value
Oct 8, 2026	ZBIORNIK NA PŁYNY	UNIWERSYTECKI SZPITAL KLINICZNY W RADOMSKU	PLN 580.00
Oct 7, 2026	Asortyment medyczny	UNIWERSYTECKI SZPITAL KLINICZNY W BIAŁYMSTOKU	PLN 360.00
Oct 2, 2026	Zakup wyrobów medycznych (inactive)	SZPITAL MIEJSKI ŚW. JANA PAWŁA II W ELBLĄGU	PLN 670.00
Oct 1, 2026	Opatrunki	POWIATOWY ZAKŁAD OPIEKI ZDROWOTNEJ	PLN 12,593
Oct 1, 2026	Dostawa wyrobów medycznych i środków ochrony indywidualnej	SZPITAL WIELOSPECJALISTYCZNY W JAWORZNIE	PLN 36,693

Source: Central Register of Contracts of Public Finance Sector Units (Polish Ministry of Finance), rejestrumow.gov.pl. Company as contractor; data processed by Compabase, the Ministry of Finance is not responsible for its processed form.

Public procurement disputes (KIO)

Neomed Polska has been a party to 42 cases before the National Appeal Chamber (since 2019). It filed 19 appeals (4 upheld, 5 dismissed, 7 discontinued). In 23 cases it joined the proceedings as a participant.

Date	Case no.	Role	Other party	Outcome
May 11, 2026	KIO 1833/26	Appellant	Samodzielny Publiczny Zakład Opieki Zdrowotnej Uniwersytecki Szpital Kliniczny nr 2 Uniwersytetu Medycznego w Łodzi	Discontinued
May 11, 2026	KIO 1541/26	Appellant	Narodowy Instytut Onkologii im. Marii Skłodowskiej – Curie – Państwowy Instytut Badawczy	Dismissed
Apr 29, 2026	KIO 1276/26	Participant (on appellant's side)	Wojskowy Ośrodek Farmacji i Techniki Medycznej w Celestynowie	Dismissed
Mar 12, 2026	KIO 454/26	Participant (on appellant's side)	Szpital Uniwersytecki nr 1 im. Dr A. Jurasza w Bydgoszczy	Dismissed
Feb 24, 2026	KIO 467/26	Appellant	Uniwersytecki Szpital Kliniczny w Poznaniu	Discontinued

Authorized Representatives

Maciej Wrona – President of the Management Board

Martyna Patrycja Stańczyk – Attorney-in-fact (sole)

Manner of representation

The President of the Management Board and the Vice-President are each independently authorised to submit declarations in property and non-property matters and to sign on behalf of the company, or two members of the management board acting jointly, or a member of the management board acting jointly with a commercial proxy.

Ownership

Owner	Shares	Share value	Stake
Martyna Patrycja Stańczyk (43)	10	$1,350.62	10%
Michał Sebastian Stańczyk (43)	82	$11,075.09	82%
Others	8	$1,080.50	8%

Michał Sebastian Stańczyk and Martyna Patrycja Stańczyk hold a combined 92% – the ownership structure indicates family control.

Beneficial owners

Person	Rights
Michał Sebastian Stańczyk (43)	Shareholder of a limited liability company, 40000.0 PLN

Competitors

Name	Revenue	Website
Biochem PolskaS.A.	$13,180,007.81	biochempolska.pl
Medif sp. z o.o.sp. k.	$13,126,958.83	medif.com
PolypharmS.A.	$13,084,716.73	polypharm.pl
PromedS.A.	$12,643,674.56	promed.com.pl
AO East Europesp. z o.o.	$12,156,227.53	aoeasteurope.pl
MassmedicaS.A.	$8,216,274.00	massmedica.com
Surgical Solutionssp. z o.o.	$947,852.75	surgical-solutions.pl
MD International Medicalsp. z o.o.	$331,292.14	md-international.eu
Screenmedsp. z o.o.	$147,401.05	screenmed.pl
Jacek Frey i Wojciech FreyS.K.A.	–	frey.pl

Change history

Date	Event
2015-07-27	PKD change (Removed: 10.86.Z, 13.20, 13.30.Z, 13.9, 14.1, 14.39.Z, 18.12.Z, 18.13.Z, 20.41.Z, 20.42.Z, 22.22.Z, 42.11.Z, 42.13.Z, 43.11.Z, 43.12.Z, 43.21.Z, 43.29.Z, 43.33.Z, 43.91.Z, 43.99.Z, 46.16.Z, 46.37.Z, 46.41.Z, 46.42.Z, 46.45.Z, 47.73.Z, 49.42.Z, 52.10.B, 62.02.Z, 62.09.Z, 63.1, 63.11.Z, 63.12.Z, 63.9, 63.99.Z, 69.20.Z, 70.22.Z, 73.1, 73.11.Z, 74.30.Z, 77.12.Z, 77.32.Z, 77.33.Z, 81)
2014-03-04	Entered in the register

FAQ

Last updated: 2026-07-10